We are live on ! Find out more
ACA

Avoro Capital Advisors Portfolio holdings

AUM $10.2B
1-Year Est. Return 149.19%
This Fund
S&P 500
This Quarter Est. Return
+31.98%
1 Year Est. Return
+149.19%
3 Year Est. Return
+425.03%
5 Year Est. Return
+775.33%
10 Year Est. Return
+45,729.2%
AUM
$148M
AUM Growth
Cap. Flow
+$140M
Cap. Flow %
95.07%
Top 10 Hldgs %
69.36%
Holding
30
New
29
Increased
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 81.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VXRT
26
DELISTED
Vaxart
VXRT
$579K 0.39%
+23,508
New +$602K
RCPT
27
PUT
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
$82K 0.06%
+20,000
New +$2.02M
EXAS
28
PUT
DELISTED
Exact Sciences
EXAS
$4K ﹤0.01%
+9,600
New +$234K

Similar funds

Avoro Capital Advisors's Q4 2014 Portfolio in Review

Q4 2014 is the first quarter with a 13F filing on record for Avoro Capital Advisors, which disclosed 30 positions worth $148M. Its ten largest holdings account for 69% of the portfolio.

Its largest position is Amicus Therapeutics: 2,824,185 shares worth $23.5M.

By sector, the portfolio is most concentrated in Healthcare at 81% of assets.

  • Avoro Capital Advisors's largest Q4 2014 buy was Amicus Therapeutics: 2,824,185 shares worth $23.5M.
  • Avoro Capital Advisors's ten largest holdings make up 69% of its $148M portfolio in Q4 2014.
  • Avoro Capital Advisors disclosed 30 positions in Q4 2014, its first 13F filing on record.

Based on Avoro Capital Advisors's 13F filing for Q4 2014, filed 13 Feb 2015.